Coverage
-
July 11, 2011
Mylan Inc. on Friday exited a New Jersey suit brought by Takeda Pharmaceutical Co. Ltd. over a generic version of acid reflex drug Prevacid, though one of the generics maker's subsidiaries remains as a defendant.
1 other articles on this case.
View all »